272 related articles for article (PubMed ID: 20056794)
21. Integrative analysis of prognostic factors in Chinese core binding factor leukemia.
Wang D; Qiao C; Xiao M; Geng Z; Shang Z; He J; Huang M; Yang Y; Zhang N; Liu Y; Li J; Li C; Zhou J
Biochem Biophys Res Commun; 2012 Nov; 428(3):411-5. PubMed ID: 23107788
[TBL] [Abstract][Full Text] [Related]
22. D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations.
Yui S; Kurosawa S; Yamaguchi H; Kanamori H; Ueki T; Uoshima N; Mizuno I; Shono K; Usuki K; Chiba S; Nakamura Y; Yanada M; Kanda J; Tajika K; Gomi S; Fukunaga K; Wakita S; Ryotokuji T; Fukuda T; Inokuchi K
Ann Hematol; 2017 Oct; 96(10):1641-1652. PubMed ID: 28762080
[TBL] [Abstract][Full Text] [Related]
23. KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis.
Jawhar M; Döhner K; Kreil S; Schwaab J; Shoumariyeh K; Meggendorfer M; Span LLF; Fuhrmann S; Naumann N; Horny HP; Sotlar K; Kubuschok B; von Bubnoff N; Spiekermann K; Heuser M; Metzgeroth G; Fabarius A; Klein S; Hofmann WK; Kluin-Nelemans HC; Haferlach T; Döhner H; Cross NCP; Sperr WR; Valent P; Reiter A
Leukemia; 2019 May; 33(5):1124-1134. PubMed ID: 30635631
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of c-KIT and CEBPA mutations in 33 patients with corebinding factor (Non-M3) acute myeloid leukemia.
Mao X; Yin R; Liu L; Zhou Y; Yang C; Fang C; Jiang H; Guo Q; Tian X
Pediatr Neonatol; 2023 Jul; 64(4):435-441. PubMed ID: 36809862
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic value of KIT and other clonal genetic mutations in core-binding factor acute myeloid leukemia].
Wu TM; Xue SL; Li Z; Yu JQ; Wang J; Wang BR; Wan CL; Shen XD; Qiu QC; Bao XB; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):646-653. PubMed ID: 34547870
[No Abstract] [Full Text] [Related]
26. Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
Chen W; Xie H; Wang H; Chen L; Sun Y; Chen Z; Li Q
PLoS One; 2016; 11(1):e0146614. PubMed ID: 26771376
[TBL] [Abstract][Full Text] [Related]
27. KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group.
Shimada A; Taki T; Tabuchi K; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
Blood; 2006 Mar; 107(5):1806-9. PubMed ID: 16291592
[TBL] [Abstract][Full Text] [Related]
28. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study.
Rogers HJ; Wang X; Xie Y; Davis AR; Thakral B; Wang SA; Borthakur G; Cantu MD; Margolskee EM; Philip JKS; Sukhanova M; Bagg A; Bueso-Ramos CE; Orazi A; Arber DA; Hsi ED; Hasserjian RP
Am J Hematol; 2020 Jul; 95(7):799-808. PubMed ID: 32249963
[TBL] [Abstract][Full Text] [Related]
29. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H; Nakamura N; Tomizawa D; Saito AM; Kiyokawa N; Horibe K; Nishinaka-Arai Y; Tokumasu M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
Pediatr Blood Cancer; 2016 Aug; 63(8):1394-9. PubMed ID: 27135782
[TBL] [Abstract][Full Text] [Related]
30. Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.
Klein K; Kaspers G; Harrison CJ; Beverloo HB; Reedijk A; Bongers M; Cloos J; Pession A; Reinhardt D; Zimmerman M; Creutzig U; Dworzak M; Alonzo T; Johnston D; Hirsch B; Zapotocky M; De Moerloose B; Fynn A; Lee V; Taga T; Tawa A; Auvrignon A; Zeller B; Forestier E; Salgado C; Balwierz W; Popa A; Rubnitz J; Raimondi S; Gibson B
J Clin Oncol; 2015 Dec; 33(36):4247-58. PubMed ID: 26573082
[TBL] [Abstract][Full Text] [Related]
31. Identification and in silico analysis of noval alteration Arg420Gly in KIT proto oncogene among acute myeloid leukemia patients.
Akram AM; Hassan M; Chaudhary A; Hayat S; Ali Q; Hussain T; Zafar A; Javed MA
Sci Rep; 2022 Nov; 12(1):19252. PubMed ID: 36357474
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11.
Ishikawa Y; Kawashima N; Atsuta Y; Sugiura I; Sawa M; Dobashi N; Yokoyama H; Doki N; Tomita A; Kiguchi T; Koh S; Kanamori H; Iriyama N; Kohno A; Moriuchi Y; Asada N; Hirano D; Togitani K; Sakura T; Hagihara M; Tomikawa T; Yokoyama Y; Asou N; Ohtake S; Matsumura I; Miyazaki Y; Naoe T; Kiyoi H
Blood Adv; 2020 Jan; 4(1):66-75. PubMed ID: 31899799
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.
Cairoli R; Beghini A; Grillo G; Nadali G; Elice F; Ripamonti CB; Colapietro P; Nichelatti M; Pezzetti L; Lunghi M; Cuneo A; Viola A; Ferrara F; Lazzarino M; Rodeghiero F; Pizzolo G; Larizza L; Morra E
Blood; 2006 May; 107(9):3463-8. PubMed ID: 16384925
[TBL] [Abstract][Full Text] [Related]
34. Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
Tokumasu M; Murata C; Shimada A; Ohki K; Hayashi Y; Saito AM; Fujimoto J; Horibe K; Nagao M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Tomizawa D; Taga T; Tawa A; Tanaka S; Heike T; Adachi S
Leukemia; 2015 Dec; 29(12):2438-41. PubMed ID: 25975190
[No Abstract] [Full Text] [Related]
35. Additional chromosomal abnormalities in core-binding factor acute myeloid leukemia.
Hsiao HH; Liu YC; Wang HC; Tsai YF; Wu CH; Cho SF; Hsu JF; Huang CT; Hsiao SY; Lee CP; Chang CS; Lin SF; Liu TC
Genet Mol Res; 2015 Dec; 14(4):17028-33. PubMed ID: 26681050
[TBL] [Abstract][Full Text] [Related]
36. Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1-RUNX1T1 transcripts.
Sasaki K; Tsujimoto S; Miyake M; Uchiyama Y; Ikeda J; Yoshitomi M; Shimosato Y; Tokumasu M; Matsuo H; Yoshida K; Ohki K; Kaburagi T; Yamato G; Hara Y; Takeuchi M; Kinoshita A; Tomizawa D; Taga T; Adachi S; Tawa A; Horibe K; Hayashi Y; Matsumoto N; Ito S; Shiba N
Br J Haematol; 2021 Jul; 194(2):414-422. PubMed ID: 34120331
[TBL] [Abstract][Full Text] [Related]
37. Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.
Paschka P; Schlenk RF; Weber D; Benner A; Bullinger L; Heuser M; Gaidzik VI; Thol F; Agrawal M; Teleanu V; Lübbert M; Fiedler W; Radsak M; Krauter J; Horst HA; Greil R; Mayer K; Kündgen A; Martens U; Heil G; Salih HR; Hertenstein B; Schwänen C; Wulf G; Lange E; Pfreundschuh M; Ringhoffer M; Girschikofsky M; Heinicke T; Kraemer D; Göhring G; Ganser A; Döhner K; Döhner H
Leukemia; 2018 Jul; 32(7):1621-1630. PubMed ID: 29720733
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Systematic Review.
Ayatollahi H; Shajiei A; Sadeghian MH; Sheikhi M; Yazdandoust E; Ghazanfarpour M; Shams SF; Shakeri S
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):1-7. PubMed ID: 27613372
[TBL] [Abstract][Full Text] [Related]
39. Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center.
Duan W; Liu X; Zhao X; Jia J; Wang J; Gong L; Jiang Q; Zhao T; Wang Y; Zhang X; Xu L; Shi H; Chang Y; Liu K; Huang X; Qin Y; Jiang H
Ann Hematol; 2021 May; 100(5):1203-1212. PubMed ID: 33474629
[TBL] [Abstract][Full Text] [Related]
40. NPM1, FLT3, and c-KIT mutations in pediatric acute myeloid leukemia in Russian population.
Yatsenko Y; Kalennik O; Maschan M; Kalinina I; Maschan A; Nasedkina T
J Pediatr Hematol Oncol; 2013 Apr; 35(3):e100-8. PubMed ID: 23511494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
